How are our projects
The projects focus on issues such as:
- Optimising healthcare pathways by analysing therapeutic treatment sequences to target and address disruption points,
- Personalised medicine through the ability to identify markers for sub-populations which might benefit from a specific treatment,
- Pharmaco-economics as a means of collectively enjoying improved efficiency.
The projects focus on rare, frequent, poor prognosis and paediatric cancers. With regard to the issues explored by each individual project, they address any public and/or private data available in France (medico-administrative, clinical, real-life, genomic data, etc.).